Suggested Topics within your search.
Showing 201 - 220 results of 1,103 for search 'PHARMACOECONOMICS', query time: 0.46s Refine Results
  1. 201
    PHARMACOECONOMIC ASPECTS OF TREATMENT WITH THE INHIBITORS OF TUMOR NECROSIS FACTOR OF THE CHRONIC UVEITIS REFRACTORY TO THE BASIC THERAPY (INCLUDING AN ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS)
    by A.V. Rudakova
    Published 2011-08-01
    “.... Conclusions. The realized pharmacoeconomic analysis suggests the feasibility of adalimumab treatment...”
    Get full text
    Article
  2. 202
    A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
    Get full text
    Article
  3. 203
    Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA
    Get full text
    Article
  4. 204
    Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
    by Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S
    Published 2017-01-01
    Get full text
    Article
  5. 205
    C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
    Get full text
    Article
  6. 206
    Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India—A Cost-of-Illness Study
    Get full text
    Article
  7. 207
    The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri PharmacoEconomics (TyPE) Study
    Get full text
    Article
  8. 208
    Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis
    by Feng Y, Li C, Zhang T, Pradelli L
    Published 2017-09-01
    “... populations. A pharmacoeconomic evaluation was performed within the Chinese intensive care unit (ICU) setting...”
    Get full text
    Article
  9. 209
    Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis
    Get full text
    Article
  10. 210
    PHARMACOECONOMIC ASPECTS OF TREATMENT WITH THE INHIBITORS OF TUMOR NECROSIS FACTOR OF THE CHRONIC UVEITIS REFRACTORY TO THE BASIC THERAPY (INCLUDING AN ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS)
    by A.V. Rudakova
    Published 2011-08-01
    “.... Conclusions. The realized pharmacoeconomic analysis suggests the feasibility of adalimumab treatment...”
    Get full text
    Article
  11. 211
    Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness
    by Tiller, Kevin Wade
    Published 2008
    Get full text
    Others
  12. 212
    Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis
    by A. A. Alikhanov, N. L. Shimanovskiy
    Published 2020-11-01
    “...Objective: to conduct a comparative assessment of the pharmacoeconomic advantages of using...”
    Get full text
    Article
  13. 213
    Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease - Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition
    Get full text
    Article
  14. 214
    Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients
    Subjects: “...pharmacoeconomic...”
    Get full text
    Article
  15. 215
    Tiotropium in COPD: clinical outcomes and economic evidence
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  16. 216
    Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  17. 217
    ECONOMIC REASONS FOR GENERIC CHOICE
    Subjects: “...pharmacoeconomical analysis...”
    Get full text
    Article
  18. 218
    COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
    by O. P. Bobrova, M. M. Petrova
    Published 2015-12-01
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  19. 219
    Considerations for the US health-system pharmacist in a world of biosimilars
    by Andrea Zlatkus, Todd Bixby, Kavitha Goyal
    Published 2020-02-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  20. 220
    Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search